Alterity Therapeutics Ltd
ATHE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001131343
In the last 90 days, Alterity Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.12M in total; no superinvestor holds it.
Other share classesPRNAF
Holders of 5% or more of ATHE
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Alterity Therapeutics Ltd, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Alterity Therapeutics Ltd on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Alterity Therapeutics Ltd, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 5, 20252:03 PM ET | JPMorgan Chase & Co | 13G/A | 4.00%366.0M shares | −2.30 ppfrom 6.30%Below 5% | Apr 30, 2025 | SEC |
| May 2, 20259:59 AM ET | JPMorgan Chase & Co | 13G | 6.30%429.7M shares | New | Mar 31, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Alterity Therapeutics Ltd shares.
No Form 144 notices for Alterity Therapeutics Ltd are on file.